Loading clinical trials...

Double-blind Randomized Clinical Trial of Transcranial Magnetic Stimulation in Chronic Migraine | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT01496950

Double-blind Randomized Clinical Trial of Transcranial Magnetic Stimulation in Chronic Migraine

The purpose of this study is to determine whether active repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex is safe and effective for preventive treatment of chron...

Lead sponsor: Hospital Israelita Albert Einstein•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

NCT06810505 · Chronic Migraine

RECRUITINGPhase 3

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

NCT07018713 · Chronic Migraine

RECRUITINGNA

New Methods for Evaluating Preventive Migraine Treatment

NCT07071506 · Migraine, Migraine With or Without Aura, and more

RECRUITINGNA

Mind Body Balance for Pediatric Migraine

NCT04715685 · Headache, Headache Disorders, and more

RECRUITING

i-NEED: NEw migrainE Drugs Database

NCT07103694 · Episodic Migraine, Chronic Migraine, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 5, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment18

Start dateOct 2008

Last updatedApr 5, 2018

Condition

Chronic Migraine

Locations shown

Instituto Israelita de Ensino e Pesquisa Albert Einstein

São Paulo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 5, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions